Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 119.00
-1.00 (-0.83%)
At close: Apr 17, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.12 billion as of April 17, 2026. Its market cap has increased by 44.21% in one year.
Market Cap
6.12B
Enterprise Value
5.73B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
119.00
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.12B, an increase of 192.61%. That is a compound annual growth rate of 9.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.12B | 6.73% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kojem International | 6.18B |
| Savior Lifetec | 6.18B |
| Mycenax Biotech | 6.18B |
| CMSC, Inc. | 6.12B |
| Pro-Hawk | 6.10B |
| Pan Asia Chemical Co. | 6.08B |
| Zen Voce | 6.07B |
| Newmax Technology | 6.06B |